A federal investigation into Jim Irsay’s death raises serious questions about substance abuse and prescription practices.
Story Highlights
- Jim Irsay’s death from cardiac arrest is under FBI scrutiny.
- Investigation focuses on substance use and prescriptive practices.
- Grand jury subpoenas issued, but the Colts have not yet been contacted.
- Federal probe parallels high-profile drug cases.
FBI Investigation Unveils New Details
The death of Indianapolis Colts owner Jim Irsay in May 2025 has prompted a federal investigation led by the FBI. The inquiry centers on Irsay’s substance use, specifically the prescription of opioids and ketamine by California addiction specialist Dr. Harry Haroutunian.
Despite the cardiac arrest listed as the cause of death, the absence of an autopsy and the doctor’s presence at the Beverly Hills Hotel during the incident have raised eyebrows.
The investigation, which involves a grand jury subpoena issued in Los Angeles, seeks records related to Irsay’s substance use and his relationship with Dr. Haroutunian. As of now, the Indianapolis Colts have confirmed awareness of the investigation but stated they have not been contacted or subpoenaed by federal authorities.
Examining the Context and Concerns
Jim Irsay’s history of substance abuse is well-documented. His struggles with prescription drugs were public knowledge, including a 2014 conviction for intoxicated driving. Irsay’s relapse into addiction treatment involving ketamine raises concerns, especially amid parallels to other high-profile cases like that of Matthew Perry.
The federal probe’s focus on controlled substances and prescriptive practices indicates a broader interest in addressing potential irregularities in addiction treatment.
The FBI is investigating the death of former Colts owner Jim Irsay
The same doctor accused of supplying him with massive amounts of opioids and ketamine also signed the death certificate and ruled it a “natural” death per @washingtonpost pic.twitter.com/Eb9R8d4ekt
— Bussin' With The Boys (@BussinWTB) January 22, 2026
The involvement of federal agencies, including the DEA, underscores the seriousness of the case. This investigation could have significant implications for addiction treatment standards and the oversight of medical professionals prescribing controlled substances.
As the investigation unfolds, the Colts’ organization, now led by Irsay’s daughters, faces potential disruptions during this period of ownership transition.
The Broader Impact on the NFL and Society
The investigation into Irsay’s death could have far-reaching effects on the NFL and the broader societal approach to addiction treatment. The scrutiny on the distribution of substances like ketamine could lead to stricter regulations and oversight.
This case highlights the ongoing challenges of addressing addiction within high-profile communities and the potential consequences of prescriptive practices that may enable substance abuse.
Death of Indianapolis Colts owner Jim Irsay under federal investigation: Sources https://t.co/AcAsEZhKHp
— Action News on 6abc (@6abc) January 24, 2026
As the federal investigation continues, the Colts’ organization, the Irsay family, and the sports community at large await further developments. The outcome of this probe could influence future policies and practices within the NFL and beyond, emphasizing the importance of responsible prescribing and the need for effective addiction treatment frameworks.
Sources:
Colts confirm FBI investigating death of former owner Jim Irsay
Death of Indianapolis Colts owner Jim Irsay under federal investigation
FBI involved in investigation of death of Colts owner Jim Irsay
